ArticleBMC microbiology2025
Technological and probiotic properties of lactic acid bacteria and yeasts isolated from Ghanaian spontaneously fermented pearl-millet porridge, Hausa koko.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Probiogenomics as a Computational Biotechnology Framework: Safety-Gated Genome Analytics for Candidate Probiotic Prioritization and Validation.Computational and structural biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spontaneous fermentation of cereals, such as for the production of Hausa koko from millet, could be improved by the use of starter cultures to enhance reproducibility and promote beneficial health effects. This study aimed to select bacteria and yeast which could be used to develop functional starter cultures for Hausa koko fermentation, by evaluating the functional properties of 70 lactic acid bacteria (LAB) and 53 yeast strains isolated during traditional processing of Hausa koko in Ghana. Initial screening of LAB genomes using the bacteriocin genome mining tool BAGEL4 and the Bacterial and Viral Bioinformatics Resource Centre identified 26 strains carrying genes potentially associated with folate, riboflavin, thiamin, nicotinate, nicotinamide, or bacteriocin production. These 26 LAB were further assessed for in vitro technological properties associated with successful fermentation, including acidification rate, exopolysaccharide production, amylase and proteolytic activity and antimicrobial properties. The tolerance to simulated gastrointestinal conditions, including low pH and bile salt, of selected LAB as well as 53 yeast strains was tested in vitro. In general, LAB exhibited good acidification properties with the greatest change in pH occurring within 4 to 8 h of fermentation, particularly in 3 strains. Five Limosilactobacillus pontis strains, 2 L. fermentum strains and one Pediococcus acidilactici strain showed exopolysaccharide production in vitro, while 17 strains demonstrated amylase activity under plate assay conditions, with 7 strains producing a clear zone of > 3.0 mm diameter on iodine-stained starch plates. Of the 26 LAB strains, 25 grew in 1% bile salt concentration, 15 grew at a pH of 2.5, and all 26 grew at a pH of 3.5 to 7, and at temperatures of 25 °C and 37 °C. Inhibitory activities against foodborne indicator pathogens were observed in vitro. All yeast strains showed similar good survival in gastrointestinal tract conditions and showed characteristics such as tolerance to various temperatures, low-to-neutral pH, and bile salt. The LAB strains L. reuteri LDOD-Sud, L. pontis LTAD-12g, and L. fermentum LMAN-Sdb, as well as the yeast strains Saccharomyces cerevisiae YSUN-Sud and Pichia kudriavzevii YTAD-12j displayed multiple in vitro traits consistent with desirable fermentative properties, suggesting potential as starter cultures for millet fermentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.